Expression of Prox1, D2-40, and WT1 in spindle cell hemangioma

Journal of Cutaneous Pathology

Volumn 41, Issue 5, 2014, Pages 447-450

  Wang, Lei ^a   Gao, Tianwen ^a   Wang, Gang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

D2 40; lymphatic; Prox1; spindle cell hemangioma; Wilms tumor 1 (WT1)

Indexed keywords

CD31 ANTIGEN; HOMEODOMAIN PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; WT1 PROTEIN; WT1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; BIOSYNTHESIS; CHILD; FEMALE; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; SKIN TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD31; CHILD; FEMALE; HEMANGIOMA; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; WT1 PROTEINS; YOUNG ADULT;

EID: 84899519839     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12309     Document Type: Article

References (28)

1. Weiss SW, Enzinger FM,. Spindle cell hemangioendothelioma. A low-grade angiosarcoma resembling a cavernous hemangioma and Kaposi's sarcoma. Am J Surg Pathol 1986; 10: 521.
2. Perkins P, Weiss SW,. Spindle cell hemangioendothelioma. An analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol 1996; 20: 1196.
3. Sangüeza OP, Requena L,. Pathology of vascular skin lesions: clinicopathologic correlations. New Jersey: Humana Press, 2003; 186.
4. Weiss SW, Goldblum JR,. Enzinger and Weiss's soft tissue tumors, 5th ed. Philadelphia, PA: Elsevier Mosby, 2008; 655.
5. Miettinen M, Wang ZF,. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Am J Surg Pathol 2012; 36: 351.
6. Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002; 7: 1505.
7. Hirakawa S, Hong YK, Harvey N, et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 2003; 162: 575.
8. Castro EC, Galambos C,. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations-a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations. Pediatr Dev Pathol 2009; 12: 187.
9. Wilting J, Papoutsi M, Christ B, et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002; 16: 1271.
10. Wang L, Gao T, Wang G,. Acral hemosideric lymphatic malformation. J Cutan Pathol 2013; 40: 657.
11. Wang L, Chen L, Yang X, Gao T, Wang G,. Benign lymphangioendothelioma: a clinical, histopathologic and immunohistochemical analysis of four cases. J Cutan Pathol 2013; 40: 945.
12. Wang L, Wang S, Gao T, Wang G,. Eccrine angiomatous hamartoma is a lymphatic proliferation. Eur J Dermatol 2013; 23: 614.
13. Partanen TA, Alitalo K, Miettinen M,. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999; 86: 2406.
14. Bhawan J, Silva C, Taungjaruwinai WM,. Inconsistent immunohistochemical expression of lymphatic and blood endothelial cell markers in cutaneous lymphangiomas. J Cutan Pathol 2013; 40: 801.
15. Suringa DWR, Ackerman AB,. Cutaneous lymphangiomas with dyschondroplasia (Maffucci's syndrome). Arch Dermatol 1970; 101: 472.
16. Pellegrini AE, Drake RD, Qualman SJ,. Spindle cell hemangioendothelioma: a neoplasm associated with Maffucci's syndrome. J Cutan Pathol 1995; 22: 173.
17. Bertucci V, Krafick BR,. What syndrome is this? Ollier's disease + vascular lesions = Maffucci syndrome. Pediatr Dermatol 1995; 12: 55.
18. Naga H, Nakamura K, Taniguchi K, Nakamura S,. Enchondromatosis with features of dysspondyloenchondromatosis and Maffucci syndrome. Clin Dysmorphol 1998; 7: 65.
19. Stenger RD, Assaf JA, Gaab MR, et al. Maffucci's syndrome as cause of chronic liquorrhoea. Pediatr Hematol Oncol 1998; 15: 179.
20. Yáñez S, Val-Bernal JF, Mira C, Echevarría MA, González-Vela MC, Arce F,. Spindle cell hemangioendotheliomas associated with multiple skeletal enchondromas: a variant of Maffucci's syndrome. Gen Diagn Pathol 1998; 143: 331.
21. Colonna G, Ascencio G, Meunier L, Guillot B,. Lymphangioma in a patient with Maffuci syndrome of the lower legs. J Mal Vasc 2002; 27: 174.
22. Auyeung J, Mohanty K, Tayton K,. Maffucci lymphangioma syndrome: an unusual variant of Ollier's disease, a case report and a review of the literature. J Pediatr Orthop B 2003; 12: 147.
23. Pansuriya TC, van Eijk R, d'Adamo P, et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet 2011; 43: 1256.
24. Amary MF, Damato S, Halai D, et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 2011; 43: 1262.
25. Kurek KC, Pansuriya TC, van Ruler MA, et al. R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations. Am J Pathol 2013; 182: 1494.
26. Lawley LP, Cerimele F, Weiss SW, et al. Expression of WT-1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol 2005; 141: 1297.
27. Al Dhaybi R, Powell J, McCuaig C, Kokta V,. Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol 2010; 63: 1052.
28. Trindade F, Tellechea O, Torrelo A, Requena L, Colmenero I,. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol 2011; 33: 569.